Singular Genomics - About the company
Singular Genomics is an acquired company based in San Diego (United States), founded in 2016 by Andrew Spaventa and Eli Glezer. It operates as a Provider of next-generation gene sequencing and multi-omics technologies. , with last known valuation of $*****. The company has 707 active competitors, including 96 funded and 83 that have exited. Its top competitors include companies like Nanopore Technologies, PacBio and Complete Genomics.
Company Details
Provider of next-generation gene sequencing and multi-omics technologies. The product pipeline comprises two initial integrated solutions which use sequencing engines for different applications. The G4 Integrated Solution is designed to target the NGS market and PX Integrated Solution is designed to target the single cell, spatial analysis, and proteomics markets.
- Website
- www.singulargenomics.com/
- Social
- Email ID
- *****@singulargenomics.com
Key Metrics
Founded Year
2016
Location
San Diego, United States
Stage
Acquired
Last Known Valuation
$***** as on Sep 01, 2024
Investors
Ranked
13th among 707 active competitors
Annual Revenue
$1M - $10M as on Dec 31, 2023
Employee Count
138 as on Sep 30, 2026
Similar Companies
Exit Details
Acquired by Deerfield (Dec 23, 2024)
Legal entities associated with Singular Genomics
Singular Genomics is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Singular Genomics Systems, Inc. CIN: 1850906 , United States, Active | Jun 02, 2016 | $1M - $10M (As on Dec 31, 2023) | - | - |
Singular Genomics Systems, Inc CIN: 6059096 , United States, Active | Jun 02, 2016 | - | 169 (As on Jun 30, 2021) | - |
Singular Genomics's acquisition details
Singular Genomics got acquired by Deerfield on Dec 23, 2024.
Click here to take a look at Singular Genomics's acquisition in detail
Sign up to download Singular Genomics' company profile
Singular Genomics's funding and investors
Singular Genomics is a funded company. Singular Genomics has 7 institutional investors.
View details of Singular Genomics's funding rounds and investors
Singular Genomics' founders and board of directors
Founder? Claim ProfileThe founders of Singular Genomics are Andrew Spaventa and Eli Glezer.
Here are the details of Singular Genomics' key team members:
- Andrew Spaventa: CSO and Co-Founder of Singular Genomics.
- Eli Glezer: CSO and Co-Founder of Singular Genomics.
View details of Singular Genomics's Founder profiles and Board Members
Singular Genomics' employee count trend
Singular Genomics has 138 employees as of Sep 26. Here is Singular Genomics's employee count trend over the years:
Uncover Singular Genomics' growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Singular Genomics's Competitors and alternates
Top competitors of Singular Genomics include Nanopore Technologies, PacBio and Complete Genomics. Here is the list of Top 10 competitors of Singular Genomics, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Nanopore Technologies 2005, Oxford (United Kingdom), Public | Manufacturer of portable and benchtop devices for real-time DNA sequencing | $1.34B | 75/100 | |
2nd |  PacBio 2004, Menlo Park (United States), Public | Developer of instrument systems and software for real-time sequencing of single-molecules | $410M | 72/100 | |
3rd | Complete Genomics 2006, San Jose (United States), Acquired | Developer of DNA sequencing platform for human genome sequencing and analysis | $125M | 66/100 | |
4th | Novogene Corporation 2011, Beijing (China), Series B | Provider of genomic services and solutions | $75M | 64/100 | |
5th | Provider of services in genome sequencing | - | 64/100 | ||
6th | Tessera Therapeutics 2017, Cambridge (United States), Series C | Provider of new genome engineering technology for treating multiple diseases | $610M | 63/100 | |
7th |  Ultima Genomics 2016, Newark (United States), Series D | Developer of high-throughput NGS instrument for research | $600M | 62/100 | |
8th | Hexagon Bio 2017, Menlo Park (United States), Series B | Provider of bioinformatics tools for the analysis of microbial genomic sequencing data | $206M | 62/100 | |
9th |  Cellanome 2020, Palo Alto (United States), Series B | Developer of the omic data platform for researchers | $119M | 59/100 | |
10th |  S2 Genomics 2016, Livermore (United States), Acquired | Developer of automated sample preparation systems for genomics | $16M | 59/100 | |
13th | Singular Genomics 2016, San Diego (United States), Acquired | Provider of next-generation gene sequencing and multi-omics technologies | - | 62/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Singular Genomics's competitors? Click here to see the top ones
Singular Genomics's Investments and acquisitions
Singular Genomics has made no investments or acquisitions yet.
Reports related to Singular Genomics
Here is the latest report on Singular Genomics's sector:
News related to Singular Genomics
Filter this listMedia has covered Singular Genomics for a total of 3 events in the last 1 year, 2 of them have been about company updates and 1 about people movement.
•
Singular Genomics Names John Stark as Chief Executive OfficerPR Newswire•Apr 28, 2026•Singular Genomics
•
Singular Genomics Designates Spatial Technologies Unit at Beth Israel Deaconess Medical Center a G4X™ Center of ExcellencePR Newswire•Mar 12, 2026•Singular Genomics
•
•
Singular Genomics Announces Closing Of Acquisition By Deerfield ManagementForexTV•Feb 21, 2025•Deerfield, Singular Genomics
•
Singular Genomics Announces Closing Of Acquisition By Deerfield ManagementGlobeNewswire•Feb 21, 2025•Deerfield, Singular Genomics
•
The M&A Class Action Firm Encourages Stockholders of OMIC, BERY, WMPN, ALVR to Act NowGlobeNewswire•Feb 06, 2025•Singular Genomics, Berry Global, William Penn Bank, Monteverde
•
OMIC Investors Have the Opportunity to Join Investigation of Singular Genomics Systems, Inc. with the Schall Law FirmPR Newswire•Jan 28, 2025•Schall Law Firm, Singular Genomics
•
Halper Sadeh LLC Investigates LBRDA, OMIC, NEUE, RSLS on Behalf of ShareholdersPR Newswire•Jan 28, 2025•Halper Sadeh, Liberty Broadband, Charter Communications, Singular Genomics and 5 others
•
Halper Sadeh LLC Investigates OMIC, CCRN, OMC on Behalf of ShareholdersBenzinga•Jan 28, 2025•Halper Sadeh, Deerfield, Singular Genomics, Cross Country and 3 others
•
Halper Sadeh LLC Investigates OMIC, AMCR, ZUO on Behalf of ShareholdersBenzinga•Jan 22, 2025•Halper Sadeh, Singular Genomics, Amcor, Zuora
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Singular Genomics
Explore our recently published companies
- DevEnvision - Islamabad based, 2013 founded, Unfunded company
- The AdSols - Rawalpindi based, 2018 founded, Unfunded company
- Coffs Harbour Used Cars - Coffs Harbour based, Unfunded company
- Devsloop Technologies - Brooklyn based, 2016 founded, Unfunded company
- Euro Recycle Cardiff - Cardiff based, 2016 founded, Unfunded company
- Beyond Plans by Maria Jose Serres-Rouse - United Kingdom based, 2016 founded, Unfunded company
